Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity

Open access
O'Connell, Jean, Lynch, Lydia, Cawood, Tom J., Kwasnik, Anna, Nolan, Niamh, Geoghegan, Justin, McCormick, Aiden, O'Farrelly, Cliona, O'Shea, Donal · 2010 · PLoS ONE

Abstract

OBJECTIVE: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. SUBJECTS: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). RESULTS: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. CONCLUSION: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0009997

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Adipocyte size results (micrometers) for Method I and Method II.
Figure 1 Adipocyte size results (micrometers) for Method I and Method II.CC BY · PubMed Central
Figure 2 Adipocyte size in obese subjects grouped by metabolic profile. Metabolically healthy obese = MHO, metabolically unhealthy obese = MUO, metabolically unhealthy obese patients with Type 2 Diabetes = DM2. Mean omental adipocyte diameter (represented by the horizontal lines) was 80.9±10.9 µm in MHO, 98.2±10.2 µm in MUO, and 104.3+/−4.2 µm in DM2. Mean subcutaneous diameter was 104.1±8.5 µm in MHO, 104.9±5.0 µm in MUO, and 113.2±6.9 µm in DM2.
Figure 2 Adipocyte size in obese subjects grouped by metabolic profile. Metabolically healthy obese = MHO, metabolically unhealthy obese = MUO, metabolically unhealthy obese patients with Type 2 Diabetes = DM2. Mean omental adipocyte diameter (represented by the horizontal lines) was 80.9±10.9 µm in MHO, 98.2±10.2 µm in MUO, and 104.3+/−4.2 µm in DM2. Mean subcutaneous diameter was 104.1±8.5 µm in MHO, 104.9±5.0 µm in MUO, and 113.2±6.9 µm in DM2.CC BY · PubMed Central
Figure 3 Correlations of adipocyte size with metabolic parameters. Omental adipocyte size (A, B and C) and subcutaneous adipocyte size (D, E and F) correlated with the degree of insulin resistance as measured by HOMA-IR, the TGL/HDL ratio, and the degree of hepatic steatosis. X = MHO, • = MUO, ○ = DM2
Figure 3 Correlations of adipocyte size with metabolic parameters. Omental adipocyte size (A, B and C) and subcutaneous adipocyte size (D, E and F) correlated with the degree of insulin resistance as measured by HOMA-IR, the TGL/HDL ratio, and the degree of hepatic steatosis. X = MHO, • = MUO, ○ = DM2CC BY · PubMed Central
Figure 4 Omental adipocyte size, metabolic parameters and hepatic fibrosis. A) Omental and subcutaneous adipocyte size, B) TGL/HDL and HOMA-IR ratios and C) Age, BMI and degree of steatosis, in subjects with hepatic steatosis alone, compared with subjects with evidence of hepatic fibrosis (** p<0.005). The data are presented as median values and inter-quartile range.
Figure 4 Omental adipocyte size, metabolic parameters and hepatic fibrosis. A) Omental and subcutaneous adipocyte size, B) TGL/HDL and HOMA-IR ratios and C) Age, BMI and degree of steatosis, in subjects with hepatic steatosis alone, compared with subjects with evidence of hepatic fibrosis (** p<0.005). The data are presented as median values and inter-quartile range.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 211

Metadata

Authors
O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D.
Affiliations
  • St. Vincent's University Hospital (IE)
  • Christchurch Hospital (NZ)
Venue
PLoS ONE
Published
2010-04-01
Volume
5
Issue
4
Pages
e9997
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2115664664
Cited by
211
References
47
Citations by year
2026: 5 · 2025: 5 · 2024: 11 · 2023: 4 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 9
FWCI
11.08
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
Funders
Medical Research Charities Group
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Keywords
metabolically healthy obesity, omental adipocytes, subcutaneous adipocytes, adipocyte size, morbid obesity, insulin resistance, hepatic steatosis, liver fibrosis, steatohepatitis, bariatric surgery, metabolic syndrome, HOMA-IR
MeSH terms
Adult, Fatty Liver, Female, Humans, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Omentum, Body Mass Index, Adipocytes, Metabolic Syndrome, Cell Size, Subcutaneous Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity. https://app.cochat.ai/papers/10.1371/journal.pone.0009997
The paper
O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D. (2010). The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity. PLoS ONE. https://doi.org/10.1371/journal.pone.0009997

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.